UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Role of anti-receptor autoantibodies in pathophysiology of scleroderma

Autoimmunity reviews, 2017-10, Vol.16 (10), p.1029-1035

2017

Volltextzugriff (PDF)

Immunoglobulin therapy in hematologic neoplasms and after hematopoietic cell transplantation

Blood reviews, 2018-03, Vol.32 (2), p.106-115

2018

Volltextzugriff (PDF)

Principles of and Advances in Immunoglobulin Replacement Therapy for Primary Immunodeficiency

Immunology and allergy clinics of North America, 2008-05, Vol.28 (2), p.413-437

Berger, Melvin, MD, PhD

2008

Volltextzugriff (PDF)

Adverse Effects of IgG Therapy

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2013-11, Vol.1 (6), p.558-566

Berger, Melvin, MD, PhD

2013

Volltextzugriff (PDF)

Bioavailability of IgG Administered by the Subcutaneous Route

Journal of clinical immunology, 2013-07, Vol.33 (5), p.984-990

2013

Volltextzugriff (PDF)

Subcutaneous Administration of IgG

Immunology and allergy clinics of North America, 2008-11, Vol.28 (4), p.779-802

Berger, Melvin, MD, PhD

2008

Volltextzugriff (PDF)

Antibodies to vaccine antigens in pooled polyclonal human IgG products

Transfusion (Philadelphia, Pa.), 2018-12, Vol.58 (S3), p.3096-3105

Berger, Melvin

2018

Volltextzugriff (PDF)

Hereditary angioedema C1-esterase inhibitor replacement therapy and coexisting autoimmune disorders: findings from a claims database

Allergy, asthma, and clinical immunology, 2020-05, Vol.16 (1), p.1-42, Article 42

2020

Volltextzugriff (PDF)

Efficient Utilization of IgG for Antibody Replacement Therapy

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2015-11, Vol.3 (6), p.1001-1002

Berger, Melvin, MD, PhD

2015

Volltextzugriff (PDF)

Parthenolide inhibits ERK and AP-1 which are dysregulated and contribute to excessive IL-8 expression and secretion in cystic fibrosis cells

Journal of inflammation (London, England), 2011-10, Vol.8 (1), p.26-26

2011

Volltextzugriff (PDF)

A pilot study of equal doses of 10% IGIV given intravenously or subcutaneously

Journal of allergy and clinical immunology, 2009-10, Vol.124 (4), p.854-856

2009

Volltextzugriff (PDF)

Choices in IgG replacement therapy for primary immune deficiency diseases: subcutaneous IgG vs. intravenous IgG and selecting an optimal dose

Current opinion in allergy and clinical immunology, 2011-12, Vol.11 (6), p.532-538

Berger, Melvin

2011

Volltextzugriff (PDF)

A history of immune globulin therapy, from the Harvard crash program to monoclonal antibodies

Current allergy and asthma reports, 2002-09, Vol.2 (5), p.368-378

Berger, Melvin

2002

Volltextzugriff (PDF)

Incidence of Infection is Inversely Related to Steady-State (Trough) Serum IgG Level in Studies of Subcutaneous IgG in PIDD

Journal of clinical immunology, 2011-10, Vol.31 (5), p.924-926

Berger, Melvin

2011

Volltextzugriff (PDF)

The role of inflammation in the pathophysiology of CF lung disease

Clinical reviews in allergy & immunology, 2002-08, Vol.23 (1), p.5-28

2002

Volltextzugriff (PDF)

Subcutaneous immunoglobulin replacement in primary immunodeficiencies

Clinical Immunology, 2004-07, Vol.112 (1), p.1-7

Berger, Melvin

2004

Volltextzugriff (PDF)

Pharmacokinetic Modeling Predicts Different IgG Exposures Using Different IVIG-Scig Dose Conversion Factors In Patients With Primary Immune Deficiency

Journal of allergy and clinical immunology, 2014-02, Vol.133 (2), p.AB181-AB181

2014

Volltextzugriff (PDF)

Subcutaneous IgG in neurologic diseases

Immunotherapy, 2014-01, Vol.6 (1), p.71-83

Berger, Melvin

2014

Volltextzugriff (PDF)

Immunologists' Attitudes On "Wear-off" Effects of IgG Replacement Therapy for Primary Immunodeficiency Disease (PIDD) Patients

Journal of allergy and clinical immunology, 2013-02, Vol.131 (2), p.AB156-AB156

2013

Volltextzugriff (PDF)

Efficacy and Tolerability Of Privigen® In Clinical Practice

Journal of allergy and clinical immunology, 2014-02, Vol.133 (2), p.AB181-AB181

2014

Volltextzugriff (PDF)

Intramuscular Versus Intravenous Immunoglobulin Replacement Therapy and Measurement of Immunoglobulin Levels During Immunoglobulin Replacement Therapy

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2013-11, Vol.1 (6), p.705-706

2013

Volltextzugriff (PDF)

Comprehensive Assessment of Serious Adverse Events Following Immunization by Health Care Providers

The Journal of pediatrics, 2013-06, Vol.162 (6), p.1276-1281.e1

2013

Volltextzugriff (PDF)

Functional IL-10 Deficiency in the Lung of Cystic Fibrosis (cftr-/-) and IL-10 Knockout Mice Causes Increased Expression and Function of B7 Costimulatory Molecules on Alveolar Macrophages

The Journal of immunology (1950), 2002-02, Vol.168 (4), p.1903-1910

2002

Volltextzugriff (PDF)

Another new mechanism of action of IGIV

Clinical immunology (Orlando, Fla.), 2011-05, Vol.139 (2), p.105-106

Berger, Melvin

2011

Volltextzugriff (PDF)

Clinical assessment of serious adverse events in children receiving 2009 H1N1 vaccination

The Pediatric infectious disease journal, 2013-02, Vol.32 (2), p.163-168

2013

Volltextzugriff (PDF)

1 – 25 von 243

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(215)
Mit Volltextzugriff
(181)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(243)
Japanisch
(17)

Erscheinungsjahr

n.n

Thema

Science & Technology
(145)
Life Sciences & Biomedicine
(140)
Humans
(136)
Female
(61)
Immunology
(61)
Biological And Medical Sciences
(54)
Adult
(51)
Male
(47)
Medical Sciences
(41)
Adolescent
(29)
Child
(29)
Middle Aged
(28)
Animals
(26)
Allergy
(24)
Fundamental And Applied Biological Sciences. Psychology
(23)
Aged
(22)
General & Internal Medicine
(20)
Immunoglobulins, Intravenous - Therapeutic Use
(19)
Infectious Diseases
(18)
Immunologic Deficiency Syndromes - Therapy
(17)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Role of anti-receptor autoantibodies in pathophysiology of scleroderma

Immunoglobulin therapy in hematologic neoplasms and after hematopoietic cell transplantation

Principles of and Advances in Immunoglobulin Replacement Therapy for Primary Immunodeficiency

Adverse Effects of IgG Therapy

Bioavailability of IgG Administered by the Subcutaneous Route

Subcutaneous Administration of IgG

Antibodies to vaccine antigens in pooled polyclonal human IgG products

Hereditary angioedema C1-esterase inhibitor replacement therapy and coexisting autoimmune disorders: findings from a claims database

Efficient Utilization of IgG for Antibody Replacement Therapy

Parthenolide inhibits ERK and AP-1 which are dysregulated and contribute to excessive IL-8 expression and secretion in cystic fibrosis cells

A pilot study of equal doses of 10% IGIV given intravenously or subcutaneously

Choices in IgG replacement therapy for primary immune deficiency diseases: subcutaneous IgG vs. intravenous IgG and selecting an optimal dose

A history of immune globulin therapy, from the Harvard crash program to monoclonal antibodies

Incidence of Infection is Inversely Related to Steady-State (Trough) Serum IgG Level in Studies of Subcutaneous IgG in PIDD

The role of inflammation in the pathophysiology of CF lung disease

Subcutaneous immunoglobulin replacement in primary immunodeficiencies

Pharmacokinetic Modeling Predicts Different IgG Exposures Using Different IVIG-Scig Dose Conversion Factors In Patients With Primary Immune Deficiency

Subcutaneous IgG in neurologic diseases

Immunologists' Attitudes On "Wear-off" Effects of IgG Replacement Therapy for Primary Immunodeficiency Disease (PIDD) Patients

Efficacy and Tolerability Of Privigen® In Clinical Practice

Intramuscular Versus Intravenous Immunoglobulin Replacement Therapy and Measurement of Immunoglobulin Levels During Immunoglobulin Replacement Therapy

Comprehensive Assessment of Serious Adverse Events Following Immunization by Health Care Providers

Functional IL-10 Deficiency in the Lung of Cystic Fibrosis (cftr-/-) and IL-10 Knockout Mice Causes Increased Expression and Function of B7 Costimulatory Molecules on Alveolar Macrophages

Another new mechanism of action of IGIV

Clinical assessment of serious adverse events in children receiving 2009 H1N1 vaccination

Suchergebnisse filtern